← All companies

XRTX

XORTX Therapeutics Inc.

XRTX Nasdaq Pharmaceutical Preparations EDGAR ↗

$2.13

+0.01 +0.47%

Key statistics

from XBRL data in SEC filings

Market cap

$27.7M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.73 – $7.05

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Aug 4, 2026 6-K FORM 6-K Jul 29, 2026 6-K FORM 6-K Jun 15, 2026 6-K FORM 6-K Jun 12, 2026 6-K FORM 6-K May 19, 2026 6-K FORM 6-K May 19, 2026 6-K FORM 6-K May 14, 2026 6-K FORM 6-K May 8, 2026 6-K FORM 6-K Apr 21, 2026 6-K FORM 6-K Apr 16, 2026 6-K FORM 6-K Apr 1, 2026 6-K FORM 6-K Mar 27, 2026 6-K FORM 6-K Mar 27, 2026 6-K FORM 6-K Mar 27, 2026 6-K FORM 6-K Mar 26, 2026 6-K FORM 6-K Mar 24, 2026 20-F Mar 20, 2026 6-K FORM 6-K Mar 19, 2026 6-K FORM 6-K Mar 13, 2026 6-K FORM 6-K Mar 5, 2026 6-K FORM 6-K Mar 3, 2026 6-K FORM 6-K Feb 27, 2026 6-K FORM 6-K Feb 5, 2026 6-K FORM 6-K Jan 2, 2026 6-K FORM 6-K Nov 17, 2025 6-K FORM 6-K Oct 31, 2025 6-K FORM 6-K Oct 29, 2025 6-K FORM 6-K Oct 23, 2025 6-K FORM 6-K Oct 21, 2025 6-K FORM 6-K Oct 21, 2025 6-K FORM 6-K Oct 21, 2025 6-K FORM 6-K Oct 17, 2025 6-K FORM 6-K Oct 17, 2025 6-K FORM 6-K Sep 4, 2025 6-K FORM 6-K Sep 3, 2025 6-K FORM 6-K Aug 15, 2025 6-K FORM 6-K Aug 7, 2025 6-K FORM 6-K Jun 26, 2025 6-K FORM 6-K May 19, 2025 6-K FORM 6-K May 16, 2025